Ligandrol LGD-4033 By Hardcore Formulations Overview & Drug Interactions
Check For Interactions With Ligandrol LGD-4033
Supplement: Ligandrol LGD-4033 by Hardcore Formulations
Ligandrol LGD-4033 Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Select Androgen Receptor Modulator LGD-4033
| Ingredient Group | Ligandrol |
|---|---|
| Category | non-nutrient/non-botanical |
Drugs that interact with Ligandrol LGD-4033 by Hardcore Formulations
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
2 Capsule(s)
|
| Maximum serving Sizes: |
2 Capsule(s)
|
| Servings per container | 30 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Select Androgen Receptor Modulator LGD-4033 |
25 mg
|
Ligandrol |
|
| Other Ingredients: |
Gelatin
Silica
Magnesium Stearate
|
|---|
Label Statments:
| General Statements |
- Sarm series
- Clinical grade
|
|---|---|
| Formulation |
- Extreme dry, dense mass & strength
|
| FDA Statement of Identity |
- Dietary Supplement
|
Brand Information
See all products by this brand
| Not Present | |
|---|---|
| Name | Hardcore Formulations |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.